Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.

Future oncology (London, England) - 1 Jul 2021

Kabra Madhusudan, Margotto Luana, Manuguid Fil

Abstract excerpt

Aim: Assess treatment patterns and healthcare resource utilization (HRU) in patients with treatment-naive (TN) or relapsed/refractory (R/R) acute myeloid leukemia (AML) in Europe. Patients & methods: Cross-sectional, retrospective, web-based survey of AML-treating healthcare professionals (HCPs) in 12 European countries. Results: 320 HCPs provided information on 1280 TN or R/R patients. Patients ineligible versus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Europe

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Neoplasm Recurrence, Local

Share to Palliative Care

Share to Patient Acceptance of Health Care

Share to Practice Patterns, Physicians'

Share to Remission Induction

Source

Identifiers

PMID: 33881356
DOI: 10.2217/fon-2021-0179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.PMID 33881356Read ↗

Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.Semantic proximity Read ↗

Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia.Semantic proximity Read ↗

Healthcare resource utilization and costs during first salvage therapy for relapsed or refractory acute myeloid leukemia in the United States.Semantic proximity Read ↗

Post-transplant maintenance therapy in patients with FLT3-mutated acute myeloid leukemia: Real-world treatment patterns and outcomes.Semantic proximity Read ↗

A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan.Semantic proximity Read ↗

Real-World Outcomes of Acute Myeloid Leukemia Patients Undergoing Treatment With Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2.Semantic proximity Read ↗

Anticancer Drug Utilization and Prescription Practices in a Saudi Cancer Center (2014-2022)Semantic proximity Read ↗

Analysis of the Gap in PCR Monitoring Availability for Patients with Chronic Myeloid Leukemia in 60 Low- and Middle-Income CountriesSemantic proximity Read ↗

Bridging Clinical Care and Everyday Life: Insights on Quality of Life in Acute Myeloid LeukemiaSemantic proximity Read ↗

The Economic Burden of Illness in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients from a Commercial and Medicaid Insurance PerspectiveSemantic proximity Read ↗

Cost consequences of unscheduled emergency admissions in cancer patients in the last year of lifeSemantic proximity Read ↗

Intensity of care in cancer patients in the last year of life: a retrospective data linkage studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.